Opdivo (nivolumab)

pCPA File Number: 21791
Negotiation Status:
Under consideration for negotiation
Indication(s):
Opdivo — in combination with fluoropyrimidine- and platinum-containing chemotherapy — for the treatment of adult patients with advanced or metastatic gastric, gastroesophageal junction or esophageal adenocarcinoma
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CADTH Project Number:
PC0259
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable